Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience.

Mert Oztas,Izzet Altun,Ali Yagiz Ayla,Emir Cerme,Cetin Demirdag,Sertac Asa,Kerim Sonmezoglu,Serdal Ugurlu

International journal of rheumatic diseases（2023）

引用 0|浏览6

暂无评分

摘要

Our study shows that rituximab may be a favorable treatment option for glucocorticoid-refractory RPF patients with high disease activity on PET-CT scans.

查看译文

关键词

positron emission tomography-computed tomography, retroperitoneal fibrosis, rituximab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要